[1]
B. H. van Riet, “Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma”, AO, vol. 64, pp. 69–77, Jan. 2025.